| Similar Articles |
|---|
 |
American Family Physician
April 15, 2001
Robert E. Hoyt & Lester Shawn |
Reducing Readmissions for Congestive Heart Failure Hospital admission for congestive heart failure is extremely common and quite expensive, although it is frequently preventable...   |
American Family Physician
October 15, 2001
Katherine L. Margo |
Spironolactone in Left-Sided Heart Failure: How Does It Fit In? The familiar diuretic spironolactone has taken on new life as a treatment for left-sided congestive heart failure. More research is necessary to determine the order and combinations of spironolactone and other medications in slowing the progression of this disease... |
American Family Physician
December 1, 2000
William E. Chavey |
The Importance of Beta Blockers in the Treatment of Heart Failure Traditionally, beta blockers have been considered to be contraindicated in patients with heart failure. Recently, however, several large randomized, controlled mortality trials have been stopped early because of the effects of beta blockers... |
American Family Physician
December 1, 2004
McConaghy & Smith |
Outpatient Treatment of Systolic Heart Failure Optimal outpatient treatment of systolic heart failure has three goals that should be pursued simultaneously: (1) control of risk factors for the development and progression of heart failure, (2) treatment of heart failure, and (3) education of patients. |
American Family Physician
December 1, 2000
Assad Movahed |
Beta Blockers and Congestive Heart Failure Heart failure is a complex condition, and its treatment requires consideration of two separate goals: symptom relief and tertiary prevention... |
American Family Physician
July 15, 2000
Showkat A. Haji |
Update on Digoxin Therapy in Congestive Heart Failure Congestive heart failure is a progressive disease with significant morbidity and mortality. Despite advances in the prevention and treatment of cardiovascular diseases, the incidence and prevalence of congestive heart failure have increased in recent years... |
American Family Physician
September 1, 2001
William E. Chavey |
Guideline for the Management of Heart Failure Caused by Systolic Dysfunction Part I: Guideline development, etiology and diagnosis... |
American Family Physician
November 15, 2000
Tarik M. Ramahi |
Beta Blocker Therapy for Chronic Heart Failure Recent studies have shown that beta blocker therapy improves survival and reduces hospitalizations in patients who have chronic heart failure and left ventricular systolic dysfunction... |
American Family Physician
August 1, 2002
Daphne P. Bicket |
Using ACE Inhibitors Appropriately Although angiotensin-converting enzyme (ACE) inhibitors have documented clinical benefits in a variety of clinical situations, the disparity between the evidence from clinical trials and bedside medicine is well documented. |
American Family Physician
October 15, 2000
Patricia A. Howard & Edward F. Ellerbeck |
Optimizing Beta-Blocker Use After Myocardial Infarction Although beta-adrenergic blockers can significantly reduce mortality after a myocardial infarction, these agents are prescribed to only a minority of patients... |
American Family Physician
February 1, 2005
Dickerson & Gibson |
Management of Hypertension in Older Persons Antihypertensive therapy has been shown to reduce morbidity and mortality in older patients with elevated systolic or diastolic blood pressures. |
American Family Physician
August 15, 2006
Morris, Hatcher & Reddy |
Digoxin Therapy for Heart Failure: An Update Digoxin therapy has long been used to treat heart failure; however, its effectiveness was not completely known until recently. Results of the Digitalis Investigation Group trial showed that adding digoxin to standard heart failure therapy had no effect on mortality. |
American Family Physician
October 1, 2002
Konzem et al. |
Controlling Hypertension in Patients with Diabetes Hypertension and diabetes mellitus are common diseases in the United States. Patients with diabetes have a much higher rate of hypertension than would be expected in the general population. Regardless of the antihypertensive agent used, a reduction in blood pressure helps to prevent diabetic complications. |
American Family Physician
March 1, 2006
Satpathy et al. |
Diagnosis and Management of Diastolic Dysfunction and Heart Failure With early diagnosis and proper management the prognosis of diastolic dysfunction is more favorable than that of systolic dysfunction. Distinguishing diastolic from systolic heart failure is essential because the optimal therapy for one may aggravate the other. |
American Family Physician
November 1, 2003
Scow et al. |
Combination Therapy with ACE Inhibitors and Angiotensin-Receptor Blockers in Heart Failure This article reviews the literature and available evidence on the use of ACE inhibitors and angiotensin-receptor blockers in combination for the treatment of patients with congestive heart failure. |
American Family Physician
September 1, 2003
Magill et al. |
New Developments in the Management of Hypertension Advances in the management of hypertension have refined our understanding of systolic blood pressure, nutrition, medication selection, and hypertension in special populations. |
American Family Physician
August 1, 2002
Mark W. Niedfeldt |
Managing Hypertension in Athletes and Physically Active Patients Athletes and other physically active patients should be screened for hypertension and given appropriate therapy if needed. |
American Family Physician
July 15, 2002
Dana E. King |
Acute Management of Atrial Fibrillation: Part I. Rate and Rhythm Control Atrial fibrillation is the arrhythmia most commonly encountered in family practice. Initial treatment is directed at controlling the ventricular rate. Medical or electrical cardioversion to restore sinus rhythm is the next step in patients who remain in atrial fibrillation. |
American Family Physician
March 1, 2007
Flood & Fleisher |
Preparation of the Cardiac Patient for Noncardiac Surgery Perioperative myocardial infarction (MI) is a major cause of morbidity and mortality in patients who have noncardiac surgery. |
American Family Physician
April 1, 2001
Joan Bedinghaus |
Coronary Artery Disease Prevention: What's Different for Women? Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk... |
American Family Physician
June 1, 2004
Gutierrez & Blanchard |
Diastolic Heart Failure: Challenges of Diagnosis and Treatment The outcomes of ongoing clinical trials may provide much-needed information about diastolic heart failure to move from intuitive treatment to therapy based on evidence that matters: decreased morbidity and mortality and improved quality of life. |
American Family Physician
December 1, 2003
Lyle A. Siddoway |
Amiodarone: Guidelines for Use and Monitoring Amiodarone is a potent antiarrhythmic agent that is used to treat ventricular arrhythmias and atrial fibrillation. The drug prevents the recurrence of life-threatening ventricular arrhythmias and produces a modest reduction of sudden deaths in high-risk patients. |
American Family Physician
June 15, 2005
Hanna & Wenger |
Secondary Prevention of Coronary Heart Disease in Elderly Patients A review of the scientific evidence for the secondary prevention of coronary heart disease in the elderly. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
American Family Physician
November 15, 2002
Cynthia M. Williams |
Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population. |
Nurse Practitioner
February 2011
Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
American Family Physician
June 15, 2002
A. Kesh Hebbar |
Management of Common Arrhythmias: Part I. Supraventricular Arrhythmias Family physicians frequently encounter patients with symptoms that could be related to cardiac arrhythmias, most commonly atrial fibrillation or supraventricular tachycardias. |
Nursing
June 2010
Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
Nurse Practitioner
February 2012
Wood & Gordon |
Preventing CVD in women: The NP's role This article focuses on the new American Heart Association guidelines for preventing cardiovascular disease in women and the nurse practitioner's role in implementing them. |
American Family Physician
October 15, 2006
Sharonne N. Hayes |
Preventing Cardiovascular Disease in Women The American Heart Association guidelines for cardiovascular disease prevention in women provide physicians with a clear plan for assessment and treatment of cardiovascular disease risk and personalization of treatment recommendations. |
American Family Physician
April 1, 2004
Nina Solenski |
Transient Ischemic Attacks: Part II. Treatment Risk factors for stroke should be evaluated in patients who have had a transient ischemic attack. |
American Family Physician
December 15, 2003
Ezekowitz et al. |
Stroke: Strategies for Primary Prevention Stroke is a leading cause of morbidity and mortality. Every year, approximately 500,000 Americans have a first stroke, and approximately 20 percent die within 30 days. This article summarizes strategies that have been shown to be effective in stroke prevention. |
American Family Physician
August 15, 2001
Melissa H. Hunter |
COPD: Management of Acute Exacerbations and Chronic Stable Disease Outpatient management of patients with stable COPD should be directed at improving quality of life by preventing acute exacerbations, relieving symptoms and slowing the progressive deterioration of lung function... |
American Family Physician
November 15, 2001
Melvin D. Cheitlin |
Surgery for Chronic Aortic Regurgitation: When Should It Be Considered? This article discusses the pathophysiologic basis of the signs and symptoms of aortic regurgitation, with the purpose of providing practical recommendations to help physicians determine when surgical intervention is necessary |
Nurse Practitioner
August 2009
Linda A. Howe |
Pharmacogenomics and management of cardiovascular disease Prior to the completion of the Human Genome Project in 2003, individual responses to medications were usually termed idiosyncrasies. Ethnic differences were not usually seen as genetic variants, as is the case today. |
American Family Physician
June 1, 2005
O'Brien & Chennubhotla |
Treatment of Edema Major causes of edema include venous obstruction, increased capillary permeability, and increased plasma volume secondary to sodium and water retention. A systematic approach is warranted to determine the underlying diagnosis. |
American Family Physician
June 15, 2002
A. Kesh Hebbar |
Management of Common Arrhythmias: Part II. Ventricular Arrhythmias and Arrhythmias in Special Populations Patients with established heart disease and premature ventricular complexes have a higher likelihood of developing ventricular tachycardia or fibrillation. |
American Family Physician
August 1, 2004
Wiviott & Braunwald |
Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: Part II. Coronary Revascularization, Hospital Discharge, and Post-Hospital Care In patients hospitalized with UA/NSTEMI, one of the most important decisions is the early strategy of care regarding coronary angiography and revascularization. |
American Family Physician
January 1, 2006
MODI Lowder |
Medications for Migraine Prophylaxis Sufficient evidence and consensus exist to recommend propranolol, timolol, amitriptyline, divalproex, sodium valproate, and topiramate as first-line agents for migraine prevention. |
American Family Physician
August 15, 2001
Thomas P. Guck |
Assessment and Treatment of Depression Following Myocardial Infarction Depression is an independent risk factor in the development of and mortality associated with cardiovascular disease in otherwise healthy persons... |
Nursing
March 2012
Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
Nurse Practitioner
February 2012
Jennifer M. Belavic |
Annual drug update 2011 in review Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice |
American Family Physician
October 1, 2003
Heidelbaugh et al. |
Management of Gastroesophageal Reflux Disease This article summarizes an evidence-based approach to the cost-effective management of patients with GERD. |
American Family Physician
March 15, 2006
Wilson & Sanford |
Amlodipine/Atorvastatin (Caduet) for Preventing Heart Disease Amlodipine/atorvastatin offers no added benefit in safety, tolerability, or effectiveness over amlodipine and atorvastatin taken separately. It has not been shown to improve mortality or morbidity in patients who have hypertension with or without dyslipidemia. |
American Family Physician
May 1, 2001
Beatriz Luna & Mark N. Feinglos |
Oral Agents in the Management of Type 2 Diabetes Mellitus Currently, there are five distinct classes of hypoglycemic agents available, each class displaying unique pharmacologic properties... |
Nursing
February 2009
Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
American Family Physician
January 15, 2001
Charles P. Mouton |
Common Infections in Older Adults Despite advances in antibiotic therapy, infectious diseases continue to be a major cause of mortality in older adults. The diagnostic and therapeutic nuances of managing infections in older adults create special challenges for physicians... |
American Journal of Nursing
May 2009
Kristen J. Overbaugh |
Acute Coronary Syndrome Coronary artery disease, in which atherosclerotic plaque builds up inside the coronary arteries and restricts the flow of blood (and therefore the delivery of oxygen) to the heart, continues to be the number-one killer of Americans. |
American Family Physician
November 15, 2004
Charles T. Taylor |
Eplerenone (Inspra) for Hypertension Eplerenone, a potassium-sparing diuretic similar to spironolactone, selectively blocks aldosterone to lower blood pressure. However, its safety profile is improved over spironolactone because of reduced progesterone and androgen-receptor effects. |
